Association of serum pepsinogens and gastrin-17 with Helicobacter pylori infection assessed by urea breath test
BackgroundAssociation of gastric atrophy or cancer with levels of serum pepsinogens, gastrin-17 and anti-Helicobacter pylori IgG antibody have been extensively studied. However, the association of serum pepsinogen and gastrin-17 with H. pylori infection has not been studied in a large population.Aim...
Main Authors: | Jun-peng Zhou, Chang-hai Liu, Bo-wen Liu, You-juan Wang, Mohammed Benghezal, Barry James Marshall, Hong Tang, Hong Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-08-01
|
Series: | Frontiers in Cellular and Infection Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcimb.2022.980399/full |
Similar Items
-
Serum gastrin 17, pepsinogen I and pepsinogen II in atrophic gastritis patients living in North-East of Iran
by: Mosalreza Hosseini, et al.
Published: (2013-01-01) -
Clinical value of serum pepsinogen,gastrin 17 and Helicobacter pylori IgG antibody in primary screening of gastric diseases
by: LI Nana, QI Tao, ZHU Liming
Published: (2022-08-01) -
Assessment of Serum Pepsinogens with and without Co-Testing with Gastrin-17 in Gastric Cancer Risk Assessment—Results from the GISTAR Pilot Study
by: Claudia Robles, et al.
Published: (2022-07-01) -
Pepsinogen testing for evaluation of the success of Helicobacter pylori eradication at 4 weeks after completion of therapy
by: Marcis Leja, et al.
Published: (2014-01-01) -
Analysis of gastrin‐17 and its related influencing factors in physical examination results
by: Junchao Zeng, et al.
Published: (2023-10-01)